Compare Apixaban and Vitamin-K Antagonists in Patients With Atrial Fibrillation (AF) and End-Stage Kidney Disease (ESKD)

Clinical trial NCT02933697 · COMPLETED

Trial details

NCT number: NCT02933697
Sponsor: Atrial Fibrillation Network
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Atrial Fibrillation End-stage Kidney Disease

Start date: 2017-06-20
Primary completion: 2022-07-31
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.